Clinical Research Directory
Browse clinical research sites, groups, and studies.
2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface Disease in Pt w/ oGVHD
Sponsor: University of Maryland, Baltimore
Summary
Evaluate and study the immunologic changes to the ocular surface in cancer patients.
Official title: 2177GCCC: Identifying Novel Treatment Targets and Biomarkers for Ocular Surface Disease in Patients With Ocular Graft vs Host Disease (oGVHD) a Biobank Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2022-04-27
Completion Date
2027-12-31
Last Updated
2026-02-03
Healthy Volunteers
Yes
Conditions
Interventions
The standard care exam and biological specimens' collection
During each visit, in addition to standard of care exams, certain biological specimens ( ocular surface wash, mucocellular material, corneal filaments or impression cytology of conjunctiva, blood or serum) will be collected.
Locations (1)
Geenebaum Cancer Center, University of Maryland Medical Center
Baltimore, Maryland, United States